You stopped taking a GLP-1. Maybe you'd reached your goal. Maybe the side effects became too much. Maybe insurance stopped covering it.
For some people, the transition is relatively smooth. For others, hunger gradually returns, portions that once felt satisfying start to feel less so, and food begins occupying more mental space. And eventually, the scale starts creeping back up.
The natural reaction: did I fail?
Research increasingly shows that weight regain after discontinuing GLP-1 medications is common, and it's driven by biological changes that have very little to do with willpower or discipline. A 2026 systematic review and meta-analysis published in the BMJ, analyzing 37 studies and over 9,300 adults, found that stopping weight-management medications consistently leads to weight regain, with semaglutide and tirzepatide associated with the fastest rates of return.¹
But regaining weight doesn't mean you're out of options. The more useful question is: what does your body need now?
How Much Weight Do People Regain After Stopping GLP-1s?
The West et al. 2026 BMJ meta-analysis found that for people stopping semaglutide or tirzepatide specifically, average weight regain was approximately 1.8 pounds per month, with a projected return to baseline weight by approximately 1.5 years after stopping.¹ Among those stopping these medications, the average was approximately 32 pounds lost during treatment, with an estimated 22 pounds regained within the first year after stopping.
Earlier clinical trial data tells a similar story. In the STEP 1 extension trial, participants who discontinued semaglutide regained approximately two-thirds of their previous weight loss over the following year.²
These are group averages, not individual predictions. Individual outcomes vary considerably depending on the medication, amount of initial weight loss, duration of treatment, appetite changes after stopping, muscle mass, physical activity, eating patterns, sleep, stress, genetics, and what kind of support continues afterward.
Why Do You Regain Weight After Stopping a GLP-1?
The simplest explanation isn't that your metabolism broke. It's that several biological forces influencing appetite and body weight shift when treatment ends.
Hunger and appetite suppression can fade. GLP-1 medications influence brain pathways involved in hunger, satiety, food reward, and energy intake. Once the medication is removed, those effects can diminish. For some people, this feels like hunger returning much louder than before.
Food noise may return. While taking a GLP-1, many people describe food becoming less mentally dominant. After stopping, thoughts about food and the drive to eat may return stronger than before, making it significantly harder to maintain a lower body weight.
Weight loss itself makes maintenance harder. This is critical and often overlooked. After significant weight loss, the body responds with powerful counter-regulatory changes. A landmark study in the New England Journal of Medicine found that appetite-regulating hormones, including ghrelin (which signals hunger), leptin, and peptide YY, were still significantly altered from baseline a full year after weight loss ended, with participants reporting meaningfully higher hunger than before they lost weight.³ A 2024 study published in Obesity found that when people lose weight through dieting, their resting metabolism slows down and their hunger after meals increases. What's more, the greater the metabolic slowdown, the greater the increase in post-meal hunger, meaning the body is actively working harder to push back against the lower weight.⁴ Combined with a lower resting metabolic rate, this creates a biological environment that actively works against maintaining the new weight.
Your body composition may have changed. Weight lost during GLP-1 treatment isn't exclusively fat. Some lean tissue may also be lost. Because muscle is metabolically active and one of the body's primary sites for clearing glucose, protecting or rebuilding lean mass becomes especially important during long-term maintenance.
Weight regain usually isn't a return of bad habits. Your biological environment after losing weight is different from the one you started with.
Does Weight Regain Mean Your GLP-1 Failed?
No.
Regaining after discontinuation doesn't mean the medication failed. It may mean it was doing exactly what it was designed to do, and that its effects diminished when treatment ended.
Modern obesity treatment increasingly recognizes excess body weight as a chronic, relapsing condition rather than something treated once and permanently resolved. A useful parallel: someone whose blood pressure rises after stopping an effective antihypertensive medication wouldn't conclude "the medication failed." Its therapeutic effect was no longer present. Weight-management medications can function similarly.
Regaining weight after treatment ends may tell you that your long-term maintenance plan needs to change, not that everything you did was wasted.
What to Do If You Regain Weight After Stopping a GLP-1
Don't respond with extreme restriction. Aggressive calorie cutting can make hunger, cravings, low energy, and muscle loss even harder to manage. Instead of asking "how little can I eat?", ask "how can I make my current appetite easier to manage?"
Figure out what changed. Did you notice more hunger, more food noise, lower activity, reduced strength, or different sleep? The reason regain occurred can help determine the most useful next step. Often the answer points toward habits: the eating patterns, movement routines, and sleep consistency that were easier to maintain while the medication was doing some of the biological heavy lifting.
Revisit your treatment plan. Weight regain is information. It may mean you need more behavioral support, a nutrition adjustment, more resistance training, medication again, or a different medication strategy. The goal is to identify what made maintenance harder and build habits strong enough to work without medication-level appetite suppression.
Don't treat regain as something to punish yourself for. Treat it as data telling you the current plan isn't providing enough support.
Should You Restart a GLP-1 After Weight Regain?
For some people, restarting or continuing obesity medication may be appropriate. This decision should be made with a qualified healthcare provider.
Questions worth discussing with a clinician: why did you stop originally? How much weight has returned? How strongly have hunger, cravings, and food noise returned? How did you tolerate the medication previously? Are there other approaches that might be more appropriate now?
Long-term management may involve continued pharmacotherapy, a different medication strategy, structured behavioral treatment, medication combined with ongoing metabolic support, or other evidence-based approaches. The goal isn't being on or off medication. It's finding the level of support that allows someone to maintain meaningful health improvements long term.
How to Lose Regained Weight After Stopping a GLP-1
Rebuild satiety before cutting more food. Build meals around protein, fiber, minimally processed foods, appropriate carbohydrates, and healthy fats. Rather than making meals smaller, make them harder to become hungry after.
Prioritize protein across the day. Protein supports satiety, helps preserve or rebuild lean mass, and supports resistance-training adaptations. A 2024 systematic review and meta-analysis of 47 randomized controlled trials published in Clinical Nutrition ESPEN found that enhanced protein intake significantly prevented muscle mass decline during weight loss in adults with overweight and obesity (SMD 0.75; 95% CI 0.41 to 1.10).⁵ Distribute meaningful amounts across meals rather than concentrating most protein at dinner.
Treat resistance training as part of the plan, not an add-on. More muscle means greater capacity for glucose disposal and protection against lean-mass loss. Focus on progressive resistance training rather than simply adding more cardio.
Use movement strategically around meals. A 10 to 20 minute walk after meals can activate skeletal muscle and increase glucose uptake in ways that support both metabolic health and long-term weight management.
Pay attention to which meals trigger hunger later. If you're consistently ravenous at 3pm, ask what lunch looked like: the protein content, fiber, total meal size, and carbohydrate quality. The meal before the hunger often tells you more than the snack after it.
Be specific about sleep. Insufficient sleep can increase hunger, alter food preferences, and reduce insulin sensitivity. If appetite feels dramatically harder to manage after poor sleep, that's biological information, not a motivation problem.
How to Maintain Weight Loss After Stopping GLP-1s Long Term
The GLP-1 window is valuable precisely because it gives you something otherwise hard to get: a period of reduced pressure around food. Hunger is quieter. Food decisions feel less fraught. That window is an opportunity to build habits that don't depend on the medication to hold.
The research on who keeps weight off long term is consistent. A 2025 systematic review published in Cureus found that the most consistent predictors of sustained weight loss were behavioral: regular physical activity, dietary restraint, psychological health, rather than the amount of weight lost or the method used to lose it.⁶ It's the people who built a relationship with food, movement, sleep, and stress that supports a lower weight without requiring constant willpower. Those habits are built during the window the medication opens, not after it closes.
Maintenance is an active treatment phase, not a finish line. Pay attention to early signals before significant weight returns: trends in hunger, food noise, strength, and glucose patterns. These often emerge before the scale moves, giving you time to adjust.
A CGM makes the connection between habits and outcomes visible in real time. Which breakfasts keep you satisfied for hours? How does poor sleep show up in your appetite the next day? These patterns, once visible, become the foundation of habits you can sustain. Body composition tracking adds another layer, helping you distinguish fat loss from muscle loss.
If you're currently on a GLP-1 and thinking ahead, our GLP-1 companion, Signos Essentials, is designed for this exact moment. It pairs CGM data with personalized coaching so you're building the habits and metabolic awareness now that sustain your results in the future when treatment changes or stops. For someone not yet using a GLP-1 or CGM but looking for a smarter, more complete approach to weight loss, Signos+ combines GLP-1 treatment with our CGM, so you can lose weight effectively while building the habits that help keep it off.
----
This article is for general informational purposes and is not a substitute for personalized medical advice. If you have questions about GLP-1 medications or your weight management plan, speak with your healthcare provider.
Topics discussed in this article:
References
- West, S., Scragg, J., Aveyard, P., et al. (2026). Weight regain following the cessation of medication for weight management: a systematic review and meta-analysis. BMJ, 392, e085304. https://doi.org/10.1136/bmj-2025-085304
- Wilding, J. P. H., et al. (STEP 1 Study Group). (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725
- Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011). Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine, 365(17), 1597–1604. https://doi.org/10.1056/NEJMoa1105816
- Lopez Torres, S. Y., Aukan, M. I., Gower, B. A., & Martins, C. (2024). Adaptive thermogenesis, at the level of resting energy expenditure, after diet alone or diet plus bariatric surgery. Obesity, 32(6), 1169–1178. https://doi.org/10.1002/oby.24031
- Kokura, Y., Ueshima, J., Saino, Y., & Maeda, K. (2024). Enhanced protein intake on maintaining muscle mass, strength, and physical function in adults with overweight/obesity: A systematic review and meta-analysis. Clinical Nutrition ESPEN, 63, 417–426. https://doi.org/10.1016/j.clnesp.2024.06.030
- Ozojide, K. O., Adjei, E. M., Aderinola, O. M., et al. (2025). Genetic and behavioral predictors of long-term weight loss maintenance: a systematic review of evidence from observational and genetic studies. Cureus, 17(7), e88571. https://doi.org/10.7759/cureus.88571



